trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenomyosis D062788 1 associated lipids
Capsule Opacification D058442 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
von Hippel-Lindau Disease D006623 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Hypesthesia D006987 1 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Chromosome Inversion D007446 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Visceral Pain D059265 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Ganglioneuroma D005729 2 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Osteomalacia D010018 5 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Retinoblastoma D012175 12 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Carcinoma D002277 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Translocation, Genetic D014178 20 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Breast Neoplasms D001943 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Glioblastoma D005909 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Yoshikawa M et al. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. 2010 Eur. J. Pharmacol. pmid:20553909
Kim HN et al. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. 2009 Eur. J. Pharmacol. pmid:19766111
Lee CS et al. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. 2010 Eur. J. Pharmacol. pmid:20868669
Chen CJ et al. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells. 2008 Eur. J. Pharmacol. pmid:18590721
Kim B et al. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. 2008 Eur. J. Pharmacol. pmid:18550052
Wu Y and Guo SW Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17296257
Wu Y and Guo SW Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. 2008 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17376583
Hohl M and Thiel G Cell type-specific regulation of RE-1 silencing transcription factor (REST) target genes. 2005 Eur. J. Neurosci. pmid:16262660
Serrat N et al. Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages. 2012 Eur. J. Immunol. pmid:22865229
Zheng J et al. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC). 2015 Eur. J. Immunol. pmid:26255980
Ma XX et al. Histone deacetylase inhibitor trichostatin A modulates cell cycles in A2780 human ovarian cancer cell lines. 2009 Eur. J. Gynaecol. Oncol. pmid:19697617
Chao KC et al. Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells. 2010 Eur. J. Gynaecol. Oncol. pmid:20882882
Yu J et al. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela. 2012 Eur. J. Gynaecol. Oncol. pmid:22873101
Sourlingas TG et al. Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees. 2001 Eur. J. Cell Biol. pmid:11824792
Galiová G et al. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. 2008 Eur. J. Cell Biol. pmid:18396346
He D et al. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. 2012 Eur. J. Cancer Prev. pmid:22273848
Luo Y et al. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. 2013 Eur. J. Cancer pmid:23040637
Gray SG et al. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. 2009 Eur. J. Cancer pmid:19818596
Chambers AE et al. Histone acetylation-mediated regulation of genes in leukaemic cells. 2003 Eur. J. Cancer pmid:12736119
Lietz M et al. RE-1 silencing transcription factor (REST) regulates human synaptophysin gene transcription through an intronic sequence-specific DNA-binding site. 2003 Eur. J. Biochem. pmid:12492469
Girardot V et al. Relationship between core histone acetylation and histone H1(0) gene activity. 1994 Eur. J. Biochem. pmid:7925412
Astrand C et al. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. 2004 Eur. J. Biochem. pmid:15009194
Stöckel B et al. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. 2000 Eur. J. Biochem. pmid:10691972
Ishiguro K and Sartorelli AC Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A. 2004 Eur. J. Biochem. pmid:15182353
Coleman SL et al. Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages. 2011 Eur J Nutr pmid:21046125
Shiau RJ et al. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. 2010 Eur J Nutr pmid:19639378
Chen Y et al. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. 2009 Eur J Med Chem pmid:19136179
Marrazzo A et al. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. 2011 Eur J Med Chem pmid:21055848
Hou J et al. Structure-based optimization of click-based histone deacetylase inhibitors. 2011 Eur J Med Chem pmid:21621883
Huang D et al. A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. 2012 Eur J Med Chem pmid:22465091
Ragno R et al. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. 2008 Eur J Med Chem pmid:17698257
Bertrand P Inside HDAC with HDAC inhibitors. 2010 Eur J Med Chem pmid:20223566
Smetana K et al. To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. 2008 Jul-Sep Eur J Histochem pmid:18840553
Duharcourt S and Yao MC Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila. 2002 Eukaryotic Cell pmid:12455963
Juranek SA et al. snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. 2005 Eukaryotic Cell pmid:16278460
Tong K et al. Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. 2012 Eukaryotic Cell pmid:22771823
García I et al. Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. 2004 Eukaryotic Cell pmid:14871945
Hoffmann K et al. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? 2008 Epilepsy Res. pmid:18538545
Meier BC and Wagner BK Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. 2014 Epigenomics pmid:24811789
Poplineau M et al. Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. 2011 Epigenomics pmid:22126296
Barr MP et al. VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. 2015 Epigenomics pmid:26479311
Bhargavan B et al. Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island. 2013 Epigenetics pmid:23386123
Ooi JY et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. 2015 Epigenetics pmid:25941940
Devaney JM et al. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. 2015 Epigenetics pmid:25864488
Huisman C et al. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. 2015 Epigenetics pmid:25830725
Fan H et al. Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. 2012 Epigenetics pmid:23092945
Chen J et al. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. 2010 Epigenetics pmid:20505343
Mateen S et al. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. 2012 Epigenetics pmid:22965008
Good KV et al. Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity. 2017 Epigenetics pmid:29099289
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Zhang YW et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. 2014 Epigenetics pmid:24699858
Deneberg S et al. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. 2014 Epigenetics pmid:24686393
Soriano FX et al. Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. 2009 Epigenetics pmid:19430206
da Costa Prando E et al. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. 2011 Epigenetics pmid:22139571
Tost J et al. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines. 2011 Epigenetics pmid:21775817
Costa VL et al. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. 2011 Epigenetics pmid:21847011
Yang PM et al. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. 2012 Epigenetics pmid:22419072
Mayor R et al. Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. 2011 Epigenetics pmid:21852760
Singh T et al. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. 2013 Epigenetics pmid:23221619
Li Q and Chen H Silencing of Wnt5a during colon cancer metastasis involves histone modifications. 2012 Epigenetics pmid:22522911
Uchida H et al. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2007 Endocrinology pmid:17068141
Cho JH et al. DNA methylation regulates placental lactogen I gene expression. 2001 Endocrinology pmid:11459782
Walker GE et al. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. 2001 Endocrinology pmid:11517158
Yacqub-Usman K et al. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. 2013 Endocrinology pmid:23539512
Ho AK et al. Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. 2007 Endocrinology pmid:17628002
Li Q et al. Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation. 2018 Endocrinology pmid:29718165
Uchida H et al. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2005 Endocrinology pmid:16123169
Zhang J et al. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. 2011 Endocrinology pmid:21406501
Mao C and Shapiro DJ A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells. 2000 Endocrinology pmid:10875235
Hu JF et al. Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. 2000 Endocrinology pmid:11108251
Yang Y et al. The histone code regulating expression of the imprinted mouse Igf2r gene. 2003 Endocrinology pmid:12975326
López-Solache I et al. Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect. 2002 Endocrine pmid:12588052
Ruh MF et al. The effects of histone acetylation on estrogen responsiveness in MCF-7 cells. 1999 Endocrine pmid:10709763
Kim SH et al. The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells. 2016 Endocrine pmid:26219406
Baradari V et al. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. 2006 Endocr. Relat. Cancer pmid:17158768
Dong X et al. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. 2011 Endocr. Relat. Cancer pmid:21367844
Biernacka KM et al. Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. 2013 Endocr. Relat. Cancer pmid:23959956
Kogai T et al. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. 2006 Endocr. Relat. Cancer pmid:16954431
Pianta A et al. Nucleophosmin delocalization in thyroid tumour cells. 2011 Endocr. Pathol. pmid:21258971
Oride A et al. Trichostatin A specifically stimulates gonadotropin FSHβ gene expression in gonadotroph LβT2 cells. 2014 Endocr. J. pmid:24430728
Nakada Y et al. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells. 2015 Endocr. J. pmid:26497760
Gay S et al. Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions. 2010 EMBO Rep. pmid:20671737
Taddei A et al. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? 2005 EMBO Rep. pmid:15940285
Williams SA et al. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. 2006 EMBO J. pmid:16319923
Murphy JC et al. Control of cytomegalovirus lytic gene expression by histone acetylation. 2002 EMBO J. pmid:11867539
Krämer OH et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. 2003 EMBO J. pmid:12840003
Kasper LH et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. 2005 EMBO J. pmid:16237459
Nielsen AL et al. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. 1999 EMBO J. pmid:10562550
Jordan A et al. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. 2001 EMBO J. pmid:11285236
Van Lint C et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. 1996 EMBO J. pmid:8605881
Wong J et al. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. 1998 EMBO J. pmid:9430643
Clayton AL et al. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. 2000 EMBO J. pmid:10899125
O'Neill LP et al. A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. 1999 EMBO J. pmid:10329635
O'Neill LP and Turner BM Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. 1995 EMBO J. pmid:7664735
Schmittwolf C et al. In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. 2005 EMBO J. pmid:15660132
Ciana P et al. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. 1998 EMBO J. pmid:9857194
Méndez-Pertuz M et al. The thyroid hormone receptor antagonizes CREB-mediated transcription. 2003 EMBO J. pmid:12805224
Criqui-Filipe P et al. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. 1999 EMBO J. pmid:10369679
Craig JM et al. Centromeric chromatin pliability and memory at a human neocentromere. 2003 EMBO J. pmid:12743043
Muth V et al. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. 2001 EMBO J. pmid:11250901